(Q40801080)

23 September 2017

title

Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens (English)

1 reference

23 September 2017

6

1 reference

23 September 2017

M Linnebacher

1

1 reference

23 September 2017

J Gebert

2

1 reference

23 September 2017

W Rudy

3

1 reference

23 September 2017

S Woerner

4

1 reference

23 September 2017

Y P Yuan

5

1 reference

23 September 2017

M von Knebel Doeberitz

7

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

International Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

93

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

6-11

1 reference

Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins

23 September 2017

cites work

1 reference

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

21 January 2018

1 reference

Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1.

21 January 2018

1 reference

Genetic instability in colorectal cancers

21 January 2018

1 reference

Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

21 January 2018

1 reference

Microsatellite instability in cancer of the proximal colon

21 January 2018

1 reference

Mammalian DNA mismatch repair

21 January 2018

1 reference

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

21 January 2018

1 reference

Association of replication error positive phenotype with lymphocyte infiltration in endometrial cancers.

21 January 2018

1 reference

High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability

21 January 2018

1 reference

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

21 January 2018

1 reference

SYFPEITHI: database for MHC ligands and peptide motifs

21 January 2018

1 reference

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide

21 January 2018

1 reference

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

21 January 2018

1 reference

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

21 January 2018

1 reference

T cell defined tumor antigens

21 January 2018

1 reference

Human tumor antigens for cancer vaccine development

21 January 2018

1 reference

Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells

21 January 2018

1 reference

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope

21 January 2018

1 reference

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.

21 January 2018

1 reference

Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients

21 January 2018

1 reference

Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog

21 January 2018

1 reference

Frameshift mutator mutations

21 January 2018

1 reference

Source of unique tumour antigens

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1298

1 reference

23 September 2017

1 reference